| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1020511751 |
| P356 | DOI | 10.1007/S00534-011-0437-Y |
| P698 | PubMed publication ID | 21874278 |
| P2093 | author name string | Koichi Shimizu | |
| Masakazu Yamamoto | |||
| Ken Takasaki | |||
| Yoshihito Kotera | |||
| Atsushi Aruga | |||
| Nobuhiro Takeshita | |||
| P433 | issue | 2 | |
| P921 | main subject | dendritic cell | Q506253 |
| intrahepatic cholangiocarcinoma | Q18556554 | ||
| P304 | page(s) | 171-178 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Journal of Hepato-biliary-Pancreatic Sciences | Q25378879 |
| P1476 | title | Clinical utilization of postoperative dendritic cell vaccine plus activated T-cell transfer in patients with intrahepatic cholangiocarcinoma | |
| P478 | volume | 19 |
| Q36260577 | Activation or suppression of the immune response mediators in biliary tract cancer (BTC) patients: a systematic review and meta-analysis |
| Q64101426 | Biliary tract cancers: current knowledge, clinical candidates and future challenges |
| Q47109220 | Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers |
| Q38830071 | Current Progress in Immunotherapy for the Treatment of Biliary Cancers |
| Q37505379 | Current status of immunotherapy for the treatment of biliary tract cancer |
| Q40240474 | Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer |
| Q59135320 | Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma |
| Q39394040 | Finding for epitope within egg shell protein of human liver fluke: A clue for cholangiocarcinoma vaccine development |
| Q98159763 | Genetic analysis in the clinical management of biliary tract cancer |
| Q54934803 | High CD8+ and absence of Foxp3+ T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival. |
| Q92626019 | Honokiol-enhanced cytotoxic T lymphocyte activity against cholangiocarcinoma cells mediated by dendritic cells pulsed with damage-associated molecular patterns |
| Q39144327 | Immune-Mediated Therapies for Liver Cancer. |
| Q89624031 | Immunobiology of cholangiocarcinoma |
| Q38703148 | Immunotherapeutic Approaches to Biliary Cancer |
| Q26776184 | Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies |
| Q52676017 | Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future. |
| Q38686339 | Immunotherapy of biliary tract cancer |
| Q50116283 | Inhibition of IL-10 and TGF-β receptors on dendritic cells enhances activation of effector T-cells to kill cholangiocarcinoma cells |
| Q58737764 | Long-term survival of a patient with recurrent gallbladder carcinoma, treated with chemotherapy, immunotherapy, and surgery: a case report |
| Q38619219 | New Horizons for Precision Medicine in Biliary Tract Cancers |
| Q54476966 | New molecular and immunotherapeutic approaches in biliary cancer. |
| Q27010873 | Optimum chemotherapy for the management of advanced biliary tract cancer |
| Q36977760 | Postoperative dendritic cell vaccine plus activated T-cell transfer improves the survival of patients with invasive hepatocellular carcinoma |
| Q88575228 | Potential impact of invasive surgical procedures on primary tumor growth and metastasis |
| Q35819634 | Prognostic significance of macrophage invasion in hilar cholangiocarcinoma |
| Q41144039 | RT-qPCR analysis of the tumor antigens TOMM34 and RNF43 in samples extracted from paraffin-embedded specimens of colorectal cancer |
| Q26798443 | Targeted Therapy in Biliary Tract Cancers |
| Q36388529 | Trial watch: Dendritic cell-based interventions for cancer therapy |
| Q88222844 | Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer |
| Q52820052 | Tumor necrosis and infiltrating macrophages predict survival after curative resection for cholangiocarcinoma. |
| Q42079459 | Vaccination of biliary tract cancer patients with four peptides derived from cancer-testis antigens |
Search more.